IRDye 800CW 2-DG Optical Probe

Details zu Produkt Nr. ABIN2169594, Anbieter: Anmelden zum Anzeigen
Protein- /Substanz
Wirt
Synthetic
Konjugat
IRDye800CW
Applikation
BioImaging (BI)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Marke BrightSite™
Spezifität Tumor cells
Produktmerkmale 2-deoxyglucose (2-DG) is a glucose analog that utilizes the GLUT transporters for entry into the cell. Upon phosphorylation, it is not metabolized further and is effectively trapped within the cell. A well-established characteristic of many cancer cells is an elevated rate of metabolism, in particular, glucos uptake. IRDye 800CW 2-DG has been shown to bind tumor cells in both in vitro assays and in vivo animal studies for multiple tumor types, including: A431, SW620, MDA-MB-231, SKBr3, U87, PC3M-LN4, and 22Rv1.
glucose analog
Optical Probe
Upon receipt, store at -20 °C prior to reconstitution. After reconstitution, store at 4 °C. Reconstituted material should be used within 2 weeks. Protect from light.
Reinigung 0.2 μm nylon membrane
Applikationshinweise in vivo: 10-20 nmole per mouse (25 grams)
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Reconstitute with 1 mL sterile 1X PBS
Konzentration 0.1 nM/μL
Buffer PBS
Handhabung Protect from light.
Lagerung -20 °C
Bilder des Herstellers
Immunofluorescence (IF) image for IRDye 800CW 2-DG Optical Probe (ABIN2169594) IRDye 800CW 2-DG Optical Probe
Produkt verwendet in: Keereweer, Kerrebijn, van Driel, Xie, Kaijzel, Snoeks, Que, Hutteman, van der Vorst, Mieog, Vahrmeijer, van de Velde, Baatenburg de Jong, Löwik: "Optical image-guided surgery--where do we stand?" in: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, Vol. 13, Issue 2, pp. 199-207, 2011 (PubMed).